Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Puig, J.
space
  arrow  Rodriguez-Espinosa, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Anemia Secondary to Vitamin D Intoxication

right arrow Jaume Puig, MD; Rosa Corcoy, MD, PhD; and Jose Rodriguez-Espinosa, MD, PhD

1 April 1998 | Volume 128 Issue 7 | Pages 602-603


TO THE EDITOR:

Anemia is not usually mentioned as a complication of vitamin D intoxication but has been described in patients with and without renal failure [1]. We report on a woman with vitamin D intoxication and anemia not caused by renal failure.

A 66-year-old woman was admitted to the emergency department with hypercalcemia diagnosed after 3 weeks of severe constitutional symptoms. Three years earlier, osteoporosis had been diagnosed and a rheumatologist had prescribed an extemporaneous formulation (200 IU of vitamin D and 1 g of calcium glucobionate twice daily), which was prepared by a pharmacist. Blood tests at admission showed a calcium level of 4.04 mmol/L, a hemoglobin concentration of 103 g/L, a urea concentration of 11.2 mmol/L, and a creatinine level of 146 µmol/L. After rehydration, the hemoglobin concentration decreased to 83 g/L. Anemia was nonspecific and nonregenerative, and results of additional tests (chest radiography, mammography, abdominal ultrasonography, bone scintigraphy, fibrogastroscopy, and colonoscopy) were normal. Parathyroid hormone was undetectable, and the plasma 25-hydroxyvitamin D level was 696 nmol/L (normal range, 15 to 125 nmol/L). Two months later, while the patient was receiving a milk-free diet, plasma 25-hydroxyvitamin D levels were high, serum calcium levels were normal, and anemia had resolved. Symptoms had begun roughly when a new bottle of pills with a vitamin D content of 200 µg (8000 IU) was started.

The association of hypercalcemia and anemia suggested a neoplastic origin; this idea was rejected when results of additional examinations became available. High vitamin D levels could directly affect hematopoietic cells [2] or act through high calcium levels, which inhibit erythroid colony formation in vitro [3] and erythropoietin production in vitro [4] and in vivo [5]. That calcium is more important than vitamin D itself is supported by the course of our patient, whose anemia subsided after normalization of calcium levels, despite high vitamin D levels.

In addition to the danger of extemporaneous formulations, which carry a higher risk for error than factory-made pills, anemia is another potential complication of vitamin D intoxication.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Hospital de Sant Pau; Barcelona, Spain


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Scharfman WB, Proop S. Anemia associated with vitamin D intoxication. N Engl J Med. 1956; 255:1207-12.

2. Reichel H, Koeffler HP, Norman AW. Production of 1a,25-dihydroxyvitamin D3 by hematopoietic cells. Prog Clin Biol Res. 1990; 332:81-97.

3. Misiti J, Spivak JL. Erythropoiesis in vitro. J Clin Invest. 1979; 64:1573-9.

4. Nagakura K, Ueno M, Brookins J, Beckman BS, Fisher JW. Effects of low calcium levels on erythropoietin production by human renal carcinoma cells in culture. Am J Physiol. 1987; 253:797-801.

5. McGonigle RJ, Brookins J, Pegram BL, Fisher JW. Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia. J Pharmacol Exp Ther. 1987; 241:428-32.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Puig, J.
space
  arrow  Rodriguez-Espinosa, J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online